Zygote Microinjection for Creating Gene Cassette Knock-in and Flox Alleles in Mice
June 24th, 2022
5.8K views
The present protocol describes zygote microinjection of CRISPR-Cas9 and donor DNA to efficiently produce gene cassette knock-in and floxed mice.
Overview
This protocol outlines the zygote microinjection technique for CRISPR-Cas9 and donor DNA, facilitating the creation of gene cassette knock-in and floxed mice. This method is essential for advanced in vivo experiments in various research fields.
Key Study Components
Area of Science
- Genetic Engineering
- Neuroscience
- Transgenic Models
Background
- Genetically-modified mice are crucial for studying gene function and disease mechanisms.
- The CRISPR-Cas9 system allows precise genome editing.
- This technique supports diverse research areas including neurology and immunology.
- Efficient gene targeting can enhance experimental outcomes in mouse models.
Purpose of Study
- To develop a reliable method for creating genetically-modified mice.
- To enable advanced genetic modifications for various research applications.
- To improve the efficiency of gene targeting in mouse zygotes.
Methods Used
- Preparation of zygotes and microinjection setup.
- Injection of CRISPR components into zygotes.
- Monitoring of zygote development post-injection.
- Assessment of gene targeting efficiency and birth rates.
Main Results
- Median production efficiency for gene cassette knock-in mice was 20.8%.
- Median birth rate under nonlethal conditions was 34.0%.
- Median production efficiency for floxed mice was 7.7%.
- Demonstrated potential for high efficiency in gene editing applications.
Conclusions
- The microinjection technique is effective for generating genetically-modified mice.
- Adjustments in microinjection parameters are crucial for success.
- This method supports a wide range of genetic studies in various fields.
Frequently Asked Questions
What is the main application of this technique?
This technique is primarily used for creating genetically-modified mice for research in genetics and disease.
How does CRISPR-Cas9 improve gene editing?
CRISPR-Cas9 allows for precise and efficient modifications at specific genomic locations.
What are floxed mice?
Floxed mice have specific genes flanked by loxP sites, allowing for conditional gene knockout.
What factors influence the success of zygote microinjection?
Factors include the quality of zygotes, microinjection technique, and the composition of the injection solution.
What is the significance of gene cassette knock-in?
Gene cassette knock-in allows for the insertion of new genetic material, facilitating the study of gene function.
Who demonstrated the procedure?
The procedure was demonstrated by technical staff Natsumi Iki, Miyuki Ishida, and Yoko Tanimoto.
Executive Industry Relevance
Zygote microinjection of CRISPR-Cas9 and double-stranded DNA donors enables the generation of gene cassette knock-in and floxed alleles in mice, supporting advanced in vivo genetic models. This capability is foundational for target validation, mechanistic de-risking, and translational continuity across therapeutic areas. The method's efficiency and adaptability to various inbred strains position it as a critical tool for enterprise-scale preclinical model development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables creation of genetically precise mouse models for functional target interrogation.
- Supports mechanistic de-risking by allowing conditional and reporter allele generation.
- Facilitates hypothesis-driven validation of gene function in disease-relevant systems.
Screening & Assay Development
- Provides validated in vivo systems for downstream phenotypic and mechanistic assays.
- Ensures reproducibility and standardization through defined genetic backgrounds.
- Enables scalable production of models for compound screening and pathway analysis.
Translational & Preclinical Research
- Aligns preclinical models with human disease genetics via gene cassette knock-in and floxed alleles.
- Supports continuity from discovery through preclinical validation by enabling advanced genetic modifications.
- Reduces translational risk by providing robust, customizable in vivo platforms.
Pipeline & Workflow Integration
This microinjection protocol integrates at the interface of early discovery and preclinical model generation, enabling rapid transition from genetic hypothesis to in vivo validation.
- Discovery Biology: Accelerates hypothesis testing and pathway clarification through precise genome editing.
- Screening: Delivers reproducible, genetically defined models for assay development and compound evaluation.
- Analytics: Provides quantitative outputs such as production efficiency and birth rates for model selection.
- Translational Research: Bridges discovery and preclinical phases by supporting disease-relevant genetic modifications.
- Enterprise Reuse: Establishes a scalable, reusable workflow for generating diverse genetically modified mouse lines.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes and streamlines the production of complex genetic models.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio advancement.
- Portfolio Impact: Supports risk-adjusted prioritization and broadens the scope of preclinical research capabilities.
Implementation Considerations
- Requires technical expertise in microinjection and embryo manipulation.
- Demands specialized instrumentation such as micromanipulators and microinjectors.
- Necessitates cross-team standardization for reproducibility across genetic backgrounds.
- Adaptation may be needed for different inbred mouse strains due to variable editing efficiencies.
- Efficiency and survival rates must be monitored to optimize model generation workflows.
Biopharma FAQs
Why does null hypothesis testing matter for gene cassette knock-in validation?
Null hypothesis testing ensures that observed phenotypic changes in knock-in mice are statistically attributable to the targeted genetic modification, supporting robust target validation and reducing mechanistic ambiguity in early discovery.
How does independent variable isolation fit in zygote microinjection workflows?
Isolating variables such as genetic background and injection parameters allows teams to attribute outcomes specifically to the CRISPR-mediated modification, enhancing reproducibility and confidence in model generation.
What do quantitative dependent variable measurements enable in floxed allele production?
Quantitative metrics like production efficiency and birth rates provide objective criteria for model selection and workflow optimization, supporting data-driven advancement decisions in preclinical research.
Why are replication requirements critical for cross-functional model development?
Replication across multiple gene targets and mouse strains ensures that the microinjection protocol is robust and transferable, facilitating collaboration between discovery, screening, and translational teams.
What statistical analysis capabilities are required before implementing zygote microinjection outputs?
Teams must apply statistical analyses to assess editing efficiency, survival rates, and phenotypic outcomes, ensuring that generated models meet predefined thresholds for downstream R&D use.
